Bachelor in Chemistry and Pharmacy

The University of Chile, founded in 1842 and based in Santiago, is one of Latin America's oldest and most respected public research institutions. With a student body of around 38,938 and an international cohort of roughly 420 students, the university contributes significantly to national research, policy and public life. Its historic role and breadth of programs make it a central pillar of higher education in Chile and the region.

Offering some 191 programs across undergraduate and graduate levels, the University of Chile emphasizes critical thinking, innovation and public engagement. Academic strengths span the arts, social sciences, natural sciences, engineering and health disciplines, with research projects often focused on addressing social, economic and environmental challenges. Students benefit from strong faculty expertise, public service initiatives and interdisciplinary collaboration that link campus research to real-world impact.

Santiago provides a vibrant cultural and academic setting, and international students have access to language support, orientation services and campus networks. Applicants should be prepared for study in Spanish and consider exchange, research and scholarship opportunities to deepen academic and cultural immersion. The university remains a compelling option for students seeking rigorous study combined with meaningful engagement in Chilean society.

The Bachelor in Chemistry and Pharmacy at the University of Chile is for students interested in chemistry and its applications. This bachelor degree helps students develop a strong foundation in chemistry and pharmacology.

Students study subjects like organic chemistry, pharmacology, and toxicology. They also gain practical experience through lab work and research projects to develop analytical and critical thinking skills.

Graduates can become Pharmacists, Research Chemists, or Quality Control Specialists. They can work in hospitals, pharmaceutical companies, or research institutions like the National Institute of Health or Pfizer.